A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

In the face of such pressure, pharmaceutical companies are ... to eliminate costly inefficiencies in the drug discovery and development process. The high risk/reward ratio for drug development ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

a degree in the pharmaceutical sciences may be for you. Our undergraduate program focuses on the design, development and rational use of medication for the prevention and treatment of disease, as well ...

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...

3 CDMOs offer a wide range of comprehensive services to pharmaceutical companies, some of which can include supporting formulation development, upscaling current drug processes, clinical trial ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.